MYBL2 and ovarian cancer: Interestingly, we also found that the mRNA expression of E2F8 correlated positively with the mRNA expression of MYBL2 in female cancers, including breast cancers (R = 0.71; p = 3.42e−167), basal-like subtype (R = 0.303; p = 2.93e−04), ovarian cancers (R = 0.652; p = 5.17e−37), and cervical squamous cell carcinoma and endocervical adenocarcinoma (R = 0.322; p = 1.02e−08) (Supplementary S9).